Repeated administration of long-acting analogues of gonadotrophin-releasing hormone down-regulates the pituitary gonadotrophins and gonadal hormones. The activity of these compounds in premenopausal women with breast cancer has been previously noted. In an attempt to cause a highly selective medical
Antiestrogen treatment of postmenopausal women with primary high risk breast cancer
β Scribed by Carsten Rose; Susan M. Thorpe; Henning T. Mouridsen; Johan A. Andersen; Hans Brincker; Knud W. Andersen;
- Publisher
- Springer US
- Year
- 1983
- Tongue
- English
- Weight
- 687 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We investigated the association between smoking and risk of postmenopausal breast cancer in groups defined by high levels of estrogens, a factor known to enhance tumour progression. Two prospective cohorts of Swedish women provided 260 postmenopausal breast cancer cases and 514 controls
## Abstract A large number of women survive a diagnosis of breast cancer. Knowledge of their risk of developing a new primary cancer is important not only in relation to potential side effects of their cancer treatment, but also in relation to the possibility of shared etiology with other types of